Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty.
Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Department of Cardiology, Van Region Training and Research Hospital, 65100 Van, Turkey.
Mustafa
0000-0002-0516-9206
M
Yurtdaş
Department of Cardiology, Pamukkale University, 20070 Denizli, Turkey.
Yalin Tolga
YT
Yaylali
Department of Cardiology, Van Region Training and Research Hospital, 65100 Van, Turkey.
Nesim
N
Aladağ
Department of Cardiology, Van Region Training and Research Hospital, 65100 Van, Turkey.
Mahmut
M
Ozdemir
Department of Hematology, Van Region Training and Research Hospital, 65100 Van, Turkey.
Memiş Hilmi
MH
Atay